Housemark for pharmaceutical preparations, namely, pharmaceutical preparations for assessment, treatment, and prophylaxis of osteoarthritis, ophthalmic disease, pulmonary disease, liver disease, kidney disease, neurological disease, cognitive impairment, and mitochondrial health; pharmaceutical preparations for assessment, treatment, and prophylaxis for the health problems arising from the decline in organ systems, the immune system, and neurologic and cardiac function, respiratory tract infections, respiratory illness, immunosenescence, Parkinson's Disease, urinary tract infections, and heart disease; pharmaceutical preparations for assessment, treatment, and prophylaxis of diseases, disorders, and degenerative conditions associated with aging; pharmaceutical preparations for assessment, treatment, and prophylaxis of chronic diseases, conditions and functional disorders; pharmaceutical preparations for mitigation of aging, treatment of immunological diseases and degenerative conditions of the body, promotion of life extension, and restoration of bodily functions; pharmaceutical preparations for skin care; vaccines
Pharmaceuticals